High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 3, 2003, Pages 345-353

  Walsh, Fiona ^a   Willcock, Joanne ^b   Amyes, Sebastian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Aventis Pharma Ltd   (United Kingdom)

Author keywords

Resistance; Streptococcus pneumoniae; Telithromycin

Indexed keywords

BACTERIAL PROTEIN; DIMETHYLALLYLTRANSFERASE; ERYTHROMYCIN; GLUTAMINE; LYSINE; MACROLIDE; PROTEIN MEF A; RIBOSOME PROTEIN; RIBOSOME RNA; RNA 23S; TELITHROMYCIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM MUTANT; BASE PAIRING; CONTROLLED STUDY; DRUG ACTIVITY; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; IN VITRO STUDY; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN DOMAIN; RNA METHYLATION; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CLARITHROMYCIN; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; KETOLIDES; MACROLIDES; MEMBRANE PROTEINS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMES; STREPTOCOCCUS PNEUMONIAE;

EID: 0141852838     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg348     Document Type: Article

References (33)

1. Felmingham, D. (2002). Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Journal of Infection 44, Suppl. A, 3-10.
2. Leclercq, R. & Courvalin, P. (1991). Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrobial Agents and Chemotherapy 35, 1267-72.
3. Syrogiannopoulos, G. A., Ioanna, N. G., Tait-Kamradt, A. et al. (2001). Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece. Antimicrobial Agents and Chemotherapy 45, 342-4.
4. Nagai, K., Appelbaum, P. C., Davies, T. A. et al. (2002). Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 central and eastern European countries. Antimicrobial Agents and Chemotherapy 46, 371-7.
5. Liu, M. F. & Douthwaite, S. (2002). Activity of the ketolide telithromycin is refractory to erm monomethylation of bacterial rRNA. Antimicrobial Agents and Chemotherapy 46, 1629-33.
6. Weisblum, B. (1995). Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrobial Agents and Chemotherapy 39, 797-805.
7. Rosato, A., Vicarini, H. & Leclercq, R. (1999). Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin. Journal of Antimicrobial Chemotherapy 43, 559-62.
8. Tait-Kamradt, A. G., Reinart, R. R., Al-Lahham, A. et al. (2001). High-level ketolide-resistant streptococci. In Program and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 2001. Abstract C1-1813, p. 101. American Society for Microbiology, Washington, DC, USA.
9. Santagati, M., Iannelli, F., Oggioni, M. R. et al. (2000). Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 44, 2585-7.
10. Gay, K. & Stephens, D. S. (2001). Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. Journal of Infectious Diseases 184, 56-65.
11. Vester, B. & Douthwaite, S. (2001). Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrobial Agents and Chemotherapy 45, 1-12.
12. Farrell, D. J., Morrissey, I., Bakker, S. et al. (2002). Macrolide resistance (Macr) by ribosomal mutation detected in clinical isolates of Streptococcus pneumoniae isolated from PROTEKT 2000. Clinical Microbiology and Infection 8, Suppl. 1, Abstract O318, p. 42.
13. Depardieu, F. & Courvalin, P. (2001). Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 45, 319-23.
14. Pihlajamäki, M., Kataja, J., Seppälä, H. et al. (2002). Ribosomal mutations in Streptococcus pneumoniae clinical isolates. Antimicrobial Agents and Chemotherapy 46, 654-8.
15. Tait-Kamradt, A., Davies, T., Cronan, M. et al. (2000). Mutation in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrobial Agents and Chemotherapy 44, 2118-25.
16. Canu, A., Malbruny, B., Coquemont, M. et al. (2002). Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin and telithromycin in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 46, 125-31.
17. Worbs, M., Huber, R. & Wahl, M. C. (2000). Crystal structure of ribosomal protein L4 shows RNA-binding sites for ribosome incorporation and feedback control of the S10 operon. EMBO Journal 19, 807-18.
18. Unge, J., Åberg, A., Al-Kharadaghi, S. et al. (1998). The crystal structure of ribosomal protein L22 from Thermus thermophilus: insights into the mechanism of erythromycin resistance. Structure 6, 1577-86.
19. Gregory, S. T. & Dahlberg, A. E. (1999). Erythromycin resistance mutations in ribosomal proteins L22 and L4 perturb the higher order structure of 23S ribosomal RNA. Journal of Molecular Biology 289, 827-34.
20. Musher, D. M., Dowell, M. E., Shortridge, V. D. et al. (2002). Emergence of macrolide resistance during treatment of pneumococcal pneumonia. New England Journal of Medicine 346, 630-1.
21. Sutcliffe, J., Tait-Kamradt, A., Walker, A. et al. (2000). Macrolide resistance in pneumococci: analysis of resistant isolates obtained by passage with telithromycin. In Program and Abstracts of the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 2000. Abstract 1925, p. 117. American Society for Microbiology, Washington, DC, USA.
22. British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D.
23. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. et al. (1996). Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy 40, 2562-6.
24. Tait-Kamradt, A., Clancy, J., Cronan, M. et al. (1997). mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 41, 2251-5.
25. Sanger, F. (1977). DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, USA 74, 5463-7.
26. Davies, T. A., Dewasse, B. E., Jacobs, M. R. et al. (2000). In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 44, 414-7.
27. Rosato, A., Vicarini, H., Bonnefoy, A. et al. (1998). A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin. Antimicrobial Agents and Chemotherapy 42, 1392-6.
28. Weisblum, B. (1995). Erythromycin resistance by ribosome modification. Antimicrobial Agents and Chemotherapy 39, 577-85.
29. Douthwaite, S., Hansen, L. H. & Mauvais, P. (2000). Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA. Molecular Microbiology 36, 183-93.
30. Xiong, L., Shah, S., Mauvais, P. et al. (1999). A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre. Molecular Microbiology 35, 633-9.
31. Tettelin, H., Nelson, K. E., Paulsen, I. T. et al. (2001). Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293, 498-506.
32. Tait-Kamradt, A., Davies, T., Appelbaum, P. C. et al. (2000). Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrobial Agents and Chemotherapy 44, 3395-401.
33. Fines, M., Gueudin, M., Ramon, A. et al. (2001). In vitro selection of resistance to clindamycin related to alterations in the attenuator of the erm(TR) gene of Streptococcus pyogenes UCN1 inducibly resistant to erythromycin. Journal of Antimicrobial Chemotherapy 48, 411-6.